Drug Shortage Report for NEOSTIGMINE OMEGA

Last updated on 2024-03-27 History
Report ID 200777
Drug Identification Number 02230593
Brand name NEOSTIGMINE OMEGA
Common or Proper name Neostigmine Methylsulfate Injection USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) NEOSTIGMINE METHYLSULFATE
Strength(s) 0.5MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 10mL vial /fiole
ATC code N07AA
ATC description PARASYMPATHOMIMETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-08-03
Estimated end date 2024-03-28
Actual end date 2024-03-26
Shortage status Resolved
Updated date 2024-03-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-03-27 French Compare
v12 2024-03-27 English Compare
v11 2024-03-19 French Compare
v10 2024-03-19 English Compare
v9 2024-01-15 French Compare
v8 2024-01-15 English Compare
v7 2023-11-13 French Compare
v6 2023-11-13 English Compare
v5 2023-08-14 French Compare
v4 2023-08-14 English Compare
v3 2023-08-04 English Compare
v2 2023-08-02 French Compare
v1 2023-08-02 English Compare

Showing 1 to 13 of 13